-
Chi-Med’s fruquintinib gets approval for colorectal cancer in China
pharmaceutical-technology
September 11, 2018
Hutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China (NMPA) for the use of fruquintinib capsules to treat metastatic colorectal cancer (CRC).
-
Blood tester Guardant Health files for Nasdaq IPO
fiercebiotech
September 10, 2018
Guardant also plans to submit its test for international regulatory approvals, to help boost its coverage and reimbursements.
-
Agios, Celgene terminate partnership for developing cancer treatment
biospectrum
September 10, 2018
Agios Pharmaceuticals and Celgene have mutually agreed to terminate their collaboration and license agreement inked on April 27, 2015, to develop and commercialize products containing pan-IDH inhibitor AG-881.
-
Cross-Industry Collaboration Announced to Treat Metastatic Colorectal Cancer
americanpharmaceuticalreview
September 07, 2018
GNS Healthcare announced a cross-industry partnership with Amgen and the Alliance for Clinical Trials in Oncology (Alliance) that will apply causal artificial intelligence (AI) and simulation to combined clinical trial data to identify ...
-
SpringWorks names a CEO, inks a combo therapy deal with BeiGene
fiercebiotech
September 07, 2018
SpringWorks came to life with a clutch of drugs licensed from Pfizer, but won't rely on Pfizer’s shelves forever, with plans to boost its pipeline by partnering with other biopharmas and academic institutions.
-
New cancer treatment uses enzymes to boost immune system and fight back
worldpharmanews
August 29, 2018
Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.
-
GIC receives govt funding for immuno-oncology project
biospectrumasia
August 23, 2018
The company is currently conducting studies on a family of compounds targeted towards the Adenosine 2a receptor.
-
Researchers develop predictor for immunotherapy response in melanoma
biospectrumasia
August 22, 2018
The predictor was developed by Noam Auslander, Ph.D., with other researchers in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI)...
-
NUS researchers uncover a bidirectional regulator in cancer cells
biospectrumasia
August 21, 2018
The patent addresses Cellect's devices and methods for specifically selecting desired stem cells from a heterogeneous cell population for use in a range of medical indications.
-
Scientists develop platform to kill cancer cells
biospectrumasia
August 20, 2018
This manmade nanohybrid has been tested both in vitro and in vivo.
ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight June 2024: Globalization on the Go
